dc.contributor.author |
Shetty, Ronak
|
|
dc.contributor.author |
Inamdar, Maneesha S.
|
|
dc.date.accessioned |
2017-01-24T06:32:23Z |
|
dc.date.available |
2017-01-24T06:32:23Z |
|
dc.date.issued |
2016 |
|
dc.identifier.citation |
Shetty, R.; Inamdar, M. S., Generation of a constitutively expressing Tetracycline repressor (TetR) human embryonic stem cell line BJNhem20-TetR. Stem Cell Research 2016, 16 (2), 271-273 http://dx.doi.org/10.1016/j.scr.2015.12.043 |
en_US |
dc.identifier.citation |
Stem Cell Research |
en_US |
dc.identifier.citation |
16 |
en_US |
dc.identifier.citation |
2 |
en_US |
dc.identifier.issn |
1873-5061 |
|
dc.identifier.uri |
https://libjncir.jncasr.ac.in/xmlui/10572/2190 |
|
dc.description |
Restricted Access |
en_US |
dc.description.abstract |
Human embryonic stem cell line BJNhem20-TetR was generated using non-viral method. The construct pCAG-TetRnls was transfected using microporation procedure. BJNhem20-TetR can subsequently be transfected with any vector harbouring a TetO (Tet operator) sequence to generate doxycycline based inducible line. For example, in human embryonic stem cells, the pSuperior based TetO system has been transfected into a TetR containing line to generate OCT4 knockdown cell line (Zafarana et al., 2009). Thus BJNhem20-TetR can be used as a tool to perturb gene expression in human embryonic stem cells. (C) 2016 The Authors. Published by Elsevier B.V. |
en_US |
dc.description.uri |
1876-7753 |
en_US |
dc.description.uri |
http://dx.doi.org/10.1016/j.scr.2015.12.043 |
en_US |
dc.language.iso |
English |
en_US |
dc.publisher |
Elsevier Science Bv |
en_US |
dc.rights |
@Elsevier Science Bv, 2016 |
en_US |
dc.subject |
Cell Biology |
en_US |
dc.subject |
Biotechnology & Applied Microbiology |
en_US |
dc.title |
Generation of a constitutively expressing Tetracycline repressor (TetR) human embryonic stem cell line BJNhem20-TetR |
en_US |
dc.type |
Article |
en_US |